Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 33

The DOI matches its Crossref record.

Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines

Pourmoghadasiyan, Bahareh, Tavakkoli, Fatemeh, Beram, Farzaneh Mahmoudi, Badmasti, Farzad, Mirzaie, Amir, Kazempour, Reza, Rahimi, Shahrzad, Larijani, Setare Farokhi, Hejabi, Faranak, Sedaghatnia, Kamand · 2022 · Molecular Biology Reports

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11033-022-07199-2

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 55

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics. CA Cancer J Clin 71:33–37 · DOI · Paper page
  2. Uthamacumaran A (2020) Cancer: a turbulence problem. Neoplasia 22:759–769 · DOI
  3. Ofri A, Moore K (2020) Occult breast cancer: where are we at? Breast 54:211–215 · doi:10.1016/j.breast.2020.10.012
  4. Saraswathy M, Gong S (2013) Different strategies to overcome multidrug resistance in cancer. Biotechnol Adv 31:1397–1407 · DOI · Paper page
  5. Molani S, Madadi M, Williams D (2020) Investigating the effectiveness of breast cancer supplemental screening considering radiologists’ bias. medRxiv. https://doi.org/10.1101/2020.12.16.20248373 · doi:10.1101/2020.12.16.20248373
  6. Shi C, Yang EJ, Tao S, Ren G, Mou PK, Shim JS (2021) Natural products targeting cancer cell dependency. J Antibiot (Tokyo) 74:677–686 · DOI
  7. Yang YH, Mao JW, Tan XL (2020) Research progress on the source, production, and anti-cancer mechanisms of paclitaxel. Chin J Nat Med 18:890–897
  8. Bacanlı M, Eşi MÖ, Erdoğan H, Sarper M, Erdem O, Özkan Y (2021) Evaluation of cytotoxic and genotoxic effects of paclitaxel-loaded PLGA nanoparticles in neuroblastoma cells. Food Chem Toxicol 154:112323 · doi:10.1016/j.fct.2021.112323
  9. Giannakakou P, Robey R, Fojo T, Blagosklonny MV (2001) Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 20:3806–3813 · DOI · Paper page
  10. Zhao Y, Wang W, Pan W, Yu Y, Huang W, Gao J, Zhang Y, Zhang S (2021) WWOX promotes apoptosis and inhibits autophagy in paclitaxel-treated ovarian carcinoma cells. Mol Med Rep 23:1 · DOI
  11. Ansari MA, Thiruvengadam M, Farooqui Z, Rajakumar G, Sajid Jamal QM, Alzohairy MA, Almatroudi A, Alomary MN, Chung I-M, Al-Suhaimi EA (2021) Nanotechnology, in silico and endocrine-based strategy for delivering paclitaxel and miRNA: prospects for the therapeutic management of breast cancer. Semin Cancer Biol 69:109–128 · DOI
  12. Laffleur F, Keckeis V (2020) Advances in drug delivery systems: work in progress still needed? Int J Pharma 590:119912 · DOI · Paper page
  13. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov 20:101–124 · DOI · Paper page
  14. Moghtaderi M, Mirzaie A, Zabet N, Moammeri A, Mansoori-Kermani A (2021) Enhanced antibacterial activity of Echinacea angustifolia extract against multidrug-resistant Klebsiella pneumoniae through niosome encapsulation. Nanomaterials (Basel) 11(6):1573 · DOI
  15. Bansal S, Aggarwal G, Chandel P, Harikumar S (2013) Design and development of cefdinir niosomes for oral delivery. J Pharm Bioallied Sci 5:318 · DOI
  16. Kulkarni P, Rawtani D (2019) Application of Box–Behnken design in the preparation, optimization, and in vitro evaluation of self-assembly-based tamoxifen- and doxorubicin-loaded and dual drug-loaded niosomes for combinatorial breast cancer treatment. J Pharm Sci 108:2643–2653 · doi:10.1016/j.xphs.2019.03.020
  17. Kulkarni P, Rawtani D, Barot T (2019) Formulation and optimization of long acting dual niosomes using Box–Behnken experimental design method for combinative delivery of Ethionamide and D-cycloserine in Tuberculosis treatment Formulation and optimization of long acting dual niosomes using Box–Behnken experimental design method for combinative delivery of Ethionamide and D-cycloserine in Tuberculosis treatment. Colloid Surf A 565:131–142 · DOI
  18. Kulkarni P, Rawtani D, Barot T (2021) Design, development and in-vitro/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer’s disease. Eur J Pharm Biopharm 163:1–15 · DOI
  19. Kumar GP, Rajeshwarrao P (2011) Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharmaceutica Sinica B 1:208–219 · DOI · Paper page
  20. Sharma V, Anandhakumar S, Sasidharan M (2015) Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: an efficient carrier for cancer multi-drug delivery. Mater Sci Eng C 56:393–400 · DOI · Paper page
  21. Rochani AK, Balasubramanian S, Girija AR, Raveendran S, Borah A, Nagaoka Y, Nakajima Y, Maekawa T, Kumar DS (2016) Dual mode of cancer cell destruction for pancreatic cancer therapy using Hsp90 inhibitor loaded polymeric nano magnetic formulation. Int J Pharm 511:648–658 · DOI
  22. Hao Y-M (2011) Entrapment and release difference resulting from hydrogen bonding interactions in niosome. Int J Pharm 403:245–253 · doi:10.1016/j.ijpharm.2010.10.027
  23. Baek J-S, Cho C-W (2015) Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles. Int J Pharm 478:617–624 · DOI
  24. Baek J-S, Cho C-W (2017) A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells. Oncotarget 8:30369 · DOI
  25. Naderi S, Alikhani MY, Karimi J, Shabab N, Mohamadi N, Jaliani HZ, Saidijam M (2015) Cytoplasmic expression, optimization and catalytic activity evaluation of recombinant mature lysostaphin as an anti-staphylococcal therapeutic in Escherichia coli. Acta Medica Inter 2:72 · DOI
  26. Patil YP, Jadhav S (2014) Novel methods for liposome preparation. Chem Phys Lipids 177:8–18 · DOI · Paper page
  27. Bayindir ZS, Yuksel N (2010) Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99:2049–2060 · DOI · Paper page
  28. Bnyan R, Khan I, Ehtezazi T, Saleem I, Gordon S, O’Neill F, Roberts M (2018) Surfactant effects on lipid-based vesicles properties. J Pharm Sci 107:1237–1246 · DOI · Paper page
  29. Walker I, Gorman SA, Cox RD, Vernon DI, Griffiths J, Brown SB (2004) A comparative analysis of phenothiazinium salts for the photosensitisation of murine fibrosarcoma (RIF-1) cells in vitro. Photochem Photobiol Sci 3:653–659 · doi:10.1039/b400083h
  30. Uchegbu IF, Vyas SP (1998) Non-ionic surfactant based vesicles (niosomes) in drug delivery. Inter J Pharm 172:33–70 · DOI · Paper page
  31. Junyaprasert VB, Singhsa P, Suksiriworapong J, Chantasart D (2012) Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid. Inter J Pharm 423:303–311 · DOI · Paper page
  32. Nasseri B (2005) Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Inter J Pharma 300:95–101 · DOI · Paper page
  33. Hedayati ChM, Abolhassani Targhi A, Shamsi F, Heidari F, Salehi Moghadam Z, Mirzaie A, Behdad R, Moghtaderi M, Akbarzadeh I (2020) Niosome-encapsulated tobramycin reduced antibiotic resistance and enhanced antibacterial activity against multidrug-resistant clinical strains of Pseudomonas aeruginosa. J Biomed Mater Res A 109(6):966–980 · DOI
  34. Bayindir ZS, Yuksel N (2010) Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. J Pharm Sci 99(4):2049–2060 · DOI · Paper page
  35. Heidari F, Akbarzadeh I, Nourouzian D, Mirzaie A, Bakhshandeh H (2020) Optimization and characterization of tannic acid loaded niosomes for enhanced antibacterial and anti-biofilm activities. Adv Powder Technol 31:4768–4781 · DOI
  36. Mirzaie A, Peirovi N, Akbarzadeh I, Moghtaderi M, Heidari F, Yeganeh FE, Noorbazargan H, Mirzazadeh S, Bakhtiari R (2020) Preparation and optimization of ciprofloxacin encapsulated niosomes: a new approach for enhanced antibacterial activity, biofilm inhibition and reduced antibiotic resistance in ciprofloxacin-resistant methicillin-resistance Staphylococcus aureus. Bioorg Chem 103:104231 · DOI
  37. Shaker DS, Shaker MA, Hanafy MS (2015) Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes. Int J Pharm 493:285–294 · DOI
  38. Zare-Zardini H, Alemi A, Taheri-Kafrani A, Hosseini SA et al (2020) Assessment of a new Ginsenoside Rh2 nanoniosomal formulation for enhanced antitumor efficacy on prostate cancer: an in vitro study. Drug Des Devel Ther 14:3315–3324 · doi:10.2147/dddt.s261027
  39. Targhi AA, Moammeri A, Jamshidifar E, Abbaspour K, Sadeghi S, Lamakani L, Akbarzadeh IJBC (2021) Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities. Bioorg Chem 115:105116 · DOI
  40. Sadeghi S, Bakhshandeh H, Cohan RA, Peirovi A, Ehsani P, Norouzian D (2019) Synergistic anti-Staphylococcal activity of niosomal recombinant lysostaphin-LL-37. Int J Nanomed 14:9777 · DOI
  41. Sadeghi S, Ehsani P, Cohan RA, Sardari S, Akbarzadeh I, Bakhshandeh H, Norouzian D (2020) Design and physicochemical characterization of lysozyme loaded niosomal formulations as a new controlled delivery system. Pharma Chem J 53:921–930 · DOI
  42. Mathiowitz E (1999) Encyclopedia of controlled drug delivery. Wiley, Hoboken
  43. Ritger PL, Peppas NA (1987) A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Controlled Release 5:37–42 · DOI · Paper page
  44. Moghtaderi M, Mirzaie A, Zabet N, Moammeri A, Mansoori-Kermani A, Akbarzadeh I, Eshrati Yeganeh F, Chitgarzadeh A, Bagheri Kashtali A, Ren QJN (2021) Enhanced antibacterial activity of Echinacea angustifolia extract against multidrug-resistant Klebsiella pneumoniae through niosome encapsulation. Nanomaterials 2021(11):1573 · DOI
  45. Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 67:217–223
  46. Hemati H, Haghiralsadat F et al (2019) Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy. Artif Cells Nanomed Biotechnol 47(1):1295–1311 · DOI
  47. Balasubramaniam A, Anil Kumar V, Sadasivan Pillai K (2002) Formulation and in vivo evaluation of niosome-encapsulated daunorubicin hydrochloride. Drug Dev Ind Pharm 28:1181–1193 · DOI
  48. Jamshidifar E, Eshrati Yeganeh F, Shayan M, Tavakkoli Yaraki M, Bourbour M, Moammeri A, Akbarzadeh I, Noorbazargan H, Hossein-Khannazer N (2021) Super magnetic niosomal nanocarrier as a new approach for treatment of breast cancer: a case study on SK-BR-3 and MDA-MB-231 cell lines. Int J Mol Sci 22:7948 · DOI
  49. Lawrence M, Chauhan S, Lawrence S, Barlow D (1996) The formation, characterization and stability of non-ionic surfactant vesicles. STP Pharma Sci 6:49–60
  50. Seras-Cansell M, Ollivon M, Lesieur S (1996) Generation of non-ionic monoalkyl amphiphile-cholesterol vesicles: evidence of membrane impermeability to octyl glucoside. STP Pharma Sci 6:12–20
  51. Pardakhty A, Moazeni E, Varshosaz J, Hajhashemi V, Najafabadi AR (2011) Pharmacokinetic study of niosome-loaded insulin in diabetic rats. Daru 19:404
  52. Esfahani MKM, Alavi SE, Akbarzadeh A, Ghassemi S, Saffari Z, Farahnak M, Chiani M (2014) Pegylation of nanoliposomal paclitaxel enhances its efficacy in breast cancer. Trop J Pharma Res 13:1195–1198 · DOI
  53. Zhang G-J, Kimijima I, Onda M, Kanno M, Sato H, Watanabe T, Tsuchiya A, Abe R, Takenoshita S (1999) Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-XL, without alteration of p53 protein levels. Clin Cancer Res 5:2971–2977
  54. Strobel T, Swanson L, Korsmeyer S, Cannistra SA (1996) BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc Natl Acad Sci USA 93:14094–14099 · DOI · Paper page
  55. Dabbagh Moghaddam F, Akbarzadeh I, Marzbankia E (2021) Delivery of melittin-loaded niosomes for breast cancer treatment: an in vitro and in vivo evaluation of anti-cancer effect. Cancer Nanotechnol. https://doi.org/10.1186/s12645-021-00085-9 · DOI

Metadata

Authors
Pourmoghadasiyan, B., Tavakkoli, F., Beram, F. M., Badmasti, F., Mirzaie, A., Kazempour, R., Rahimi, S., Larijani, S. F., Hejabi, F., & Sedaghatnia, K.
Venue
Molecular Biology Reports
Published
2022-03-02
Volume
49
Issue
5
Pages
3597-3608
ISSN
  • 0301-4851
  • 1573-4978
Cited by
33
References
0
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines. https://app.cochat.ai/papers/10.1007/s11033-022-07199-2
The paper
Pourmoghadasiyan, B., Tavakkoli, F., Beram, F. M., Badmasti, F., Mirzaie, A., Kazempour, R., Rahimi, S., Larijani, S. F., Hejabi, F., & Sedaghatnia, K. (2022). Nanosized paclitaxel-loaded niosomes: formulation, in vitro cytotoxicity, and apoptosis gene expression in breast cancer cell lines. Molecular Biology Reports. https://doi.org/10.1007/s11033-022-07199-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.